Literature DB >> 1889061

Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failure.

R J Howard1, G W Moe, P W Armstrong.   

Abstract

STUDY
OBJECTIVE: The aim was to study the nature, magnitude, and time course of left ventricular structural adaptations to evolving heart failure.
DESIGN: 17 male mongrel dogs, weight 24.9(SD 3.7) kg, underwent rapid ventricular pacing (250 beats.min-1) until severe heart failure developed. Two dimensional echocardiographic and Doppler studies were performed at control, then weekly to severe heart failure. Haemodynamic measurements were made at control and severe heart failure. All studies were performed with the animals conscious during temporary sinus rhythm.
MEASUREMENTS AND MAIN RESULTS: Left ventricular diastolic volume gradually increased and the left ventricle assumed a more globular shape associated with significant wall thinning. Both the change in diastolic volume after one week of pacing and at the time of severe heart failure correlated with the time to peak heart failure. Mitral regurgitation was mild after one week of pacing, became moderate in most animals at severe heart failure, and lagged temporarily behind the increase in cardiac dimensions. The percentage increase in mitral annular size was significantly less than the increase in left ventricular cross sectional area.
CONCLUSIONS: In pacing induced heart failure (1) marked left ventricular remodelling occurs, (2) the extent of left ventricular dilatation, both early and late, correlates directly with the time required for the development of severe heart failure, (3) mitral regurgitation is an epiphenomenon and is most likely to be caused by the increase in left ventricular cross sectional area.

Entities:  

Mesh:

Year:  1991        PMID: 1889061     DOI: 10.1093/cvr/25.6.468

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

1.  Does left ventricular shape influence clinical outcome in heart failure?

Authors:  K J Harjai; R Edupuganti; E Nunez; T Turgut; L Scott; N G Pandian
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

2.  Akt signaling pathway in pacing-induced heart failure.

Authors:  Radha Ananthakrishnan; Gordon W Moe; Michael J Goldenthal; José Marín-García
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine.

Authors:  Pavel Hála; Mikuláš Mlček; Petr Ošťádal; David Janák; Michaela Popková; Tomáš Bouček; Stanislav Lacko; Jaroslav Kudlička; Petr Neužil; Otomar Kittnar
Journal:  J Vis Exp       Date:  2018-02-17       Impact factor: 1.355

Review 4.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 5.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 6.  Animal models of dilated cardiomyopathy for translational research.

Authors:  F A Recchia; V Lionetti
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

7.  Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heart.

Authors:  Gordon Moe; Andrea Konig; Peter Liu; Bodh I Jugdutt
Journal:  Mol Cell Biochem       Date:  2008-06-16       Impact factor: 3.396

8.  What About Tachycardia-induced Cardiomyopathy?

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11

Review 9.  The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases.

Authors:  Yuxia Pan; Li Xu; Xinchun Yang; Mulei Chen; Yuanfeng Gao
Journal:  Heart Fail Rev       Date:  2021-03-25       Impact factor: 4.214

Review 10.  Pathophysiology, diagnosis and treatment of tachycardiomyopathy.

Authors:  Claire A Martin; Pier D Lambiase
Journal:  Heart       Date:  2017-08-30       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.